Literature DB >> 5289429

Biochemical and pathophysiological rationale for amethopterin in psoriasis.

G D Weinstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5289429     DOI: 10.1111/j.1749-6632.1971.tb47001.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Adenyl-cyclase activity in rat-hair-cycle.

Authors:  C Cipriani; G Moretti; E Rampini; C Divano
Journal:  Arch Dermatol Res       Date:  1976-10-27       Impact factor: 3.017

Review 2.  Clinical pharmacokinetics of methotrexate.

Authors:  D D Shen; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

3.  Replication and differentiation in vitro of epidermal cells from normal human skin and from benign (psoriasis) and malignant (basal cell cancer) hyperplasia.

Authors:  B A Flaxman
Journal:  In Vitro       Date:  1972 Nov-Dec

4.  In vitro evaluation of methotrexate and azathioprine for antipsoriatic activity.

Authors:  W Raab; B Gmeiner
Journal:  Arch Dermatol Res       Date:  1975-08-29       Impact factor: 3.017

5.  Novel mechanism of resistance to folate analogues: ribonucleoside diphosphate reductase deficiency in bacteriophage T4.

Authors:  J R Johnson; G M Collins; M L Rementer; D H Hall
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

6.  Serum, tear and salivary concentrations of methotrexate in man.

Authors:  W H Steele; J F Stuart; B Whiting; J R Lawrence; K C Calman; J G McVie; G M Baird
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

7.  Antifolate activity of isoaminopterin in HeLa cells.

Authors:  H Rosemond-Hornbeak; M G Nair
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.